Can this agreement be signed electronically?

Yes. Electronic signatures are enforceable under the ESIGN Act (15 U.S.C. ch. 96) and state UETA laws in most jurisdictions, provided intent, consent, attribution, and record retention criteria are met.

Do I need a BAA for e-signature platforms?

Yes for HIPAA-covered entities: execute a Business Associate Agreement with the e-sign vendor before transmitting protected health information to ensure HIPAA compliance.

Is notarization required for these agreements?

Not typically required for routine clinical pain agreements, but state-specific rules or employer requirements may demand notarization for certain attestations—verify with counsel or state guidance.

What happens if a patient refuses monitoring?

Document the refusal, counsel on risks, and consider whether continued prescribing is clinically appropriate; refusal may be a basis for modifying or terminating the treatment plan.

How long should I keep signed agreements?

Retain them in the EHR per HIPAA and institutional policy; HIPAA requires 6 years from creation or last effective date (45 CFR §164.530(j)), and state rules may be longer.

Can I use a patient portal for signing?

Yes, provided the portal supports secure authentication, audit trails, and a BAA if PHI is transmitted; confirm the method meets ESIGN/UETA requirements for intent and attribution.

Electronic Signature
Templates
Healthcare
Healthcare Pain Management Agreement

Healthcare Pain Management Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE PAIN MANAGEMENT AGREEMENT

Patient Information

Patient Name

Date of Birth:

Gender:

Phone:

Address

Emergency Contact

Name

Phone:

Relationship:

Insurance Information

Insurance Provider

Policy Number:

Group Number:

Subscriber / Policyholder

Relevant Medical History

Current Medications (include dose and frequency) Allergies / Adverse Reactions Prior Surgeries / Hospitalizations Chronic Medical or Psychiatric Conditions

Pain Management Treatment Plan

Treating Clinician: Clinic:

Agreement Date:

This Pain Management Agreement (the Agreement) describes the plan of care for the management of chronic pain and the responsibilities of the patient and clinician. The goals of treatment include improvement in pain, function, and quality of life while minimizing medication-related risk. By signing this Agreement the patient agrees to the terms set forth below.

Prescription Management and Monitoring

I understand that medications prescribed for pain, including controlled substances, are only one component of my treatment plan. The clinician may use non-pharmacologic therapies and non-opioid medications as appropriate. If opioid therapy is indicated, it will be prescribed and monitored according to clinic policy.

I agree that all controlled medications will be obtained from a single pharmacy whenever possible. Pharmacy name: Phone:

I consent to the following as conditions of receiving controlled medications:

Consent to random urine and/or other toxicology screening as requested by the clinician Consent to random or scheduled counts of remaining medication Consent to review of state and clinic prescription monitoring records Consent to communication between clinician and pharmacy or other treating providers regarding prescriptions and treatment compliance

Prescribing parameters: Maximum daily dose (if applicable): . Refills will be provided only during established clinic visits and will not be provided early except under extraordinary documented circumstances.

Risks, Benefits, and Alternatives

I understand that opioid and certain other analgesic therapies carry risks including but not limited to sedation, respiratory depression, tolerance, physical dependence, addiction, cognitive impairment, falls, and death. I understand potential risks to pregnancy and to breastfeeding. I understand alternatives include nonopioid medications, physical therapy, interventional procedures, behavioral health interventions, and referral to pain specialists.

Patient acknowledges discussion of risks, benefits, and alternatives to the proposed pain management strategy and agrees to proceed:

Patient Responsibilities

I agree to take medications only as prescribed. I will not share, sell, or alter prescribed medications. I will store medications securely to prevent theft or misuse. I will notify the clinician of other medications or substances I am taking and of any adverse effects.

I will use a single pharmacy for controlled substance prescriptions whenever feasible I will comply with monitoring requirements including appointments, testing, and communication with the clinician I will not use illicit drugs or unauthorized controlled substances while prescribed controlled medications

Noncompliance and Termination

Failure to comply with this Agreement, evidence of diversion, inappropriate urine drug screen results, tampering with medication, or other unsafe behavior may result in modification or termination of controlled substance prescriptions and referral for addiction evaluation. The clinician will document reasons for termination and provide appropriate transition of care when clinically feasible.

Confidentiality and Information Sharing

I authorize release of my prescription and treatment information to the pharmacy and to other healthcare professionals involved in my care. I understand that the clinician will comply with applicable privacy and reporting laws, including reporting to prescription monitoring programs as required. I consent to limited disclosure when required by law or for patient safety.

Authorization and Expiration

I authorize the clinician to prescribe and manage controlled and non-controlled medications as clinically indicated. This authorization will remain in effect until revoked in writing by the patient or until the clinician determines that continued therapy is no longer appropriate. Authorization expires on:

Patient Attestation

I have read and understand the terms of this Pain Management Agreement. I have had the opportunity to ask questions and all my questions have been answered to my satisfaction. I agree to follow the treatment plan and the responsibilities described above.

Additional Patient Comments (optional)

Patient Printed Name:

Signature:

Date:

If Signed By Guardian, Relationship:

What a Healthcare Pain Management Agreement Is and When It Applies

A Healthcare Pain Management Agreement is a written contract between a clinician and a patient that documents the terms, responsibilities, and monitoring plan for treating chronic pain, frequently including controlled substances. The agreement clarifies treatment goals, dosing limits, refill procedures, urine drug screening, and conditions for referral or discharge. It also records informed consent for risks and alternative therapies, and it supports clinical decision-making and regulatory compliance. For controlled substances the agreement supplements prescription records and may be used with prescription drug monitoring program checks and HIPAA-protected medical records management.

Why Use a Formal Pain Management Agreement

A clear written agreement reduces clinical and legal ambiguity, documents informed consent, supports safe prescribing and monitoring, and creates an auditable record for care teams and payers while aligning with HIPAA privacy obligations.

Who Typically Completes and Signs This Agreement

This agreement is completed by clinicians and reviewed with patients when initiating or continuing long-term pain therapy.

Primary care physicians and pain specialists who prescribe controlled substances or coordinate chronic pain care.
Nurse practitioners and physician assistants operating under state scope-of-practice rules and prescribing authority.
Patients receiving ongoing opioid or other controlled medication therapy for chronic noncancer pain.

Both clinician and patient retain signed copies; clinicians keep the agreement in the medical record to document informed consent and monitoring plans.

Signatory Roles and Decision-Makers

Clinician — Prescriber

The licensed prescriber (MD, DO, NP, PA) is responsible for drafting treatment goals, medication limits, monitoring requirements, and for documenting clinical rationale. The prescriber must follow state prescribing statutes and standard of care for controlled substances and retain the signed agreement in the patient record.

Patient — Recipient

The patient signs to acknowledge understanding of risks, responsibilities, and monitoring procedures. The patient agrees to comply with refill rules, drug testing, and single-pharmacy requirements where specified; refusal or violation can alter the treatment plan.

Step-by-Step: How to Complete the Agreement with a Patient

Follow a clear clinical workflow when introducing and executing the agreement to ensure informed consent and documentation consistency.

01

Prepare the form: Load latest template, insert patient demographics, and prefill known diagnoses.
02

Discuss treatment: Explain goals, risks, alternatives, expected outcomes, and monitoring in plain language.
03

Agree on terms: Set medication limits, pharmacy choice, and testing schedule jointly with the patient.
04

Execute and retain: Both parties sign; store a copy in the EHR and provide the patient with a copy.

Typical Workflow for Using the Agreement in Clinical Practice

Understanding the end-to-end process helps integrate the agreement into office workflows and electronic health records.

Intake: Collect medical history, current medications, and prior treatment responses.
Assessment: Evaluate pain, function, and risk for substance use disorder.
Agreement discussion: Review terms, monitoring, and expectations with the patient.
Documentation: Sign, date, scan, and attach to the medical record with audit metadata.

Core Elements to Include in a Professional Agreement

A comprehensive agreement balances clinical detail with clear patient-facing language and operational provisions to guide ongoing care and oversight.

Treatment goals

Define measurable objectives such as pain reduction or functional improvement and the timeframes for reevaluation.

Medication controls

State specific drugs, maximum doses, refill windows, and policies on early refills and lost medications.

Monitoring plan

Describe urine drug testing, PDMP checks, pill counts, and appointment frequency for monitoring adherence and safety.

Risks and alternatives

Document risks (dependence, overdose) and nonpharmacologic or nonopioid alternatives discussed with the patient.

Termination criteria

List objective behaviors or clinical findings that may prompt tapering or referral, such as diversion or unsafe use.

Recordkeeping

State where the signed agreement will be stored and that it becomes part of the clinical record for audits.

Essential Administrative and Security Fields

Patient ID: Medical record number

Clinician ID: NPI or license number

Encounter Date: MM/DD/YYYY

Authorization: Patient consent recorded

Storage Location: EHR folder or scanned record

Privacy Note: HIPAA-protected

Common Pitfalls to Avoid

Vague dosing language that leaves room for misinterpretation and unsafe dispensing.
Failing to document patient refusal of recommended monitoring or urine testing.
Not aligning prescription monitoring checks with state-controlled-substance rules.
Storing only a patient copy without placing the signed agreement in the medical record.

Risks and Potential Consequences of Incomplete or Incorrect Agreements

Professional Discipline: State medical board action possible

Criminal Liability: Illegal prescribing risks and controlled-substance investigations

Civil Exposure: Malpractice claims for inadequate documentation

Regulatory Audit Findings: PDMP violations or recordkeeping deficiencies

Insurance Denials: Claims may be denied for lack of medical necessity evidence

Loss of Privileges: Hospital or system prescribing privileges may be restricted

Time-Sensitive Actions and Typical Deadlines

Certain tasks associated with pain agreements have timing implications for monitoring, refills, and legal compliance.

Initial Review:

Complete at treatment start and document on day of visit

Follow-up Visits:

Typically every 30–90 days depending on therapy risk

Urine Drug Screening:

As scheduled in the agreement; frequency based on risk stratification

PDMP Checks:

Per state law; usually before initial prescription and at intervals thereafter

Agreement Renewal:

Review and re-sign annually or when treatment changes

Key Milestones from Initiation to Ongoing Review

Sequence major stages to structure clinical follow-up and documentation over time.

01

Initial Evaluation

Comprehensive assessment, baseline screening, and discussion of treatment goals.

02

Agreement Execution

Patient signs agreement and receives a copy; clinician files signed record in EHR.

03

Early Follow-up

Short-interval visit (2–6 weeks) to assess response and side effects.

04

Periodic Monitoring

Scheduled PDMP checks, urine tests, and periodic documentation at set intervals.

Configuring an Electronic Workflow for the Agreement

Set up your digital workflow so the agreement integrates with clinical systems and meets audit requirements.

Field	Configuration
Patient Demographics	Auto-fill from EHR
Signature Method	E-signature with audit trail
Access Controls	Role-based clinician access
Retention Policy	Auto-archive per retention rules

Technical and Security Considerations for Electronic Execution

Choose a platform that supports secure audit trails, HIPAA compliance with a BAA, and integration with clinical workflows.

Authentication: Email link, SMS code, or stronger MFA for signer verification
Encryption: TLS 1.2/1.3 in transit; AES-256 at rest
Audit Trail: Tamper-evident timestamps, IP address, and action log

Ensure the chosen system can deliver signed PDFs, generate a certificate of completion, and support SAR/record requests while maintaining access logs.

How Practices Use Pain Management Agreements in Real Settings

Two practical examples show typical workflows and outcomes when the agreement is used consistently.

Large Primary Care Group

The clinic standardized a single agreement for all chronic pain patients to reduce variation in prescribing.

The template included PDMP checks and annual review requirements.
Standardization improved chart completeness and supported defensible prescribing in audits by ensuring consistent documentation across providers and visits.

Pain Specialty Practice

A multispecialty pain center included urine testing schedules and clear tapering criteria in every agreement.

Patients signed electronically before receiving controlled prescriptions.
Electronic execution with storage in the EHR simplified monitoring, reduced missed follow-ups, and made evidence available quickly during utilization reviews.

Practical Tips for Accurate, Efficient Agreements

Adopt consistent templates and integrate them into the EHR to reduce errors and speed execution.

Use standardized language

Employ plain-language, consistent templates with defined dosing limits and monitoring expectations to minimize clinician interpretation differences.

Automate PDMP checks

Link PDMP queries to the prescribing workflow where state systems and EHR integration permit to ensure checks are completed and recorded.

Document discussions

Summarize the consent conversation in the chart, noting alternatives discussed and patient questions to support informed consent.

Review regularly

Set calendar reminders for periodic agreement reviews and re-signing to maintain current treatment terms.

Comparison: eSignature Options for Executing Healthcare Pain Management Agreements

Selection criteria include HIPAA support (BAA), audit trail fidelity, bulk send for high-volume clinics, and per-user pricing; signNow is shown first for reference.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently Asked Questions About Using the Agreement

Answers to common operational and legal questions encountered when implementing a Healthcare Pain Management Agreement.

Need help? Contact support

Can this agreement be signed electronically?
Yes. Electronic signatures are enforceable under the ESIGN Act (15 U.S.C. ch. 96) and state UETA laws in most jurisdictions, provided intent, consent, attribution, and record retention criteria are met.
Do I need a BAA for e-signature platforms?
Yes for HIPAA-covered entities: execute a Business Associate Agreement with the e-sign vendor before transmitting protected health information to ensure HIPAA compliance.
Is notarization required for these agreements?
Not typically required for routine clinical pain agreements, but state-specific rules or employer requirements may demand notarization for certain attestations—verify with counsel or state guidance.
What happens if a patient refuses monitoring?
Document the refusal, counsel on risks, and consider whether continued prescribing is clinically appropriate; refusal may be a basis for modifying or terminating the treatment plan.
How long should I keep signed agreements?
Retain them in the EHR per HIPAA and institutional policy; HIPAA requires 6 years from creation or last effective date (45 CFR §164.530(j)), and state rules may be longer.
Can I use a patient portal for signing?
Yes, provided the portal supports secure authentication, audit trails, and a BAA if PHI is transmitted; confirm the method meets ESIGN/UETA requirements for intent and attribution.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now